Wisonic Medical Announces Completion of ￥100 Million Series B Funding Round

(VCBeat) May. 6, 2021 -- Shenzhen Wisonic Medical Technology Co., Ltd. ("Wisonic Medical") recently received several hundred million yuan in a Series B financing, led by Shenzhen Capital Group Company and its Redearth Healthcare Industry Fund, with participation from Tianjin Teda Shenglin Venture Capital, Shenzhen Gaoxin Investment, Zhongjin Pucheng and others. The funds will mainly be used for the development, listing and promotion of new products of Wisonic Medical.

Established in March 2013, Wisonic Medical is headquartered in Shenzhen with products and business covering solutions of life information support, intelligent ultrasound imaging as well as cloud medical service. "Professional Focus, Specialty Dedicated" is the unique value proposition provided by Wisonic Medical to users.

Wisonic Medical has grown into a national high-tech enterprise with completely independent intellectual property rights and integrated businesses of R&D, manufacturing, and marketing after 8 years of development. Wisonic Medical adheres to the user-centered approach and focuses on the application of specialized bedside devices in clinical. Its core products include new ultrasound scanning, cloud monitoring, Wisonic Cloud, 5G-based remote ultrasound system, and other products and services.

In 2019, Guangdong Cloud Intelligent Ultrasound Technology Engineering Center was established by Wisonic Medical. Wisonic Medical has successively built joint laboratories of cutting-edge technology with universities such as Michigan State University, Tsinghua University and Tongji University, as well as Peking University Shenzhen Hospital and other first-class hospitals to carry out industry-university-research cooperation. Meanwhile, it has become a strategic partner of China Mobile, China Unicom and Tencent in the field of 5G-based medical care.

SCGC is a leading venture capital firm in China. Co-founded by the Shenzhen Municipal Government and a group of private partners in August 1999, SCGC is now a privately and independently managed VC. Since its inception, SCGC has continuously funded private industries, supported private brands and stimulated economic growth with VC investments into up-and-coming companies throughout the world.

Redearth Healthcare Industry Fund was established in 2018, which is the first healthcare industry fund established by SCGC. It focuses on exploring the startups with strong innovation ability and great growth potential in the industry to boost the development of the industry.